Citi Appointed as Depositary Bank for Nightingale Health OYJ’s ADR Program
Citi has been appointed as the depositary bank for Nightingale Health OYJ's sponsored Level 1 American Depositary Receipt (ADR) program. The company's ADRs trade on the OTCQX platform under the symbol 'NHLTY', with each ADR representing one ordinary share. The underlying ordinary shares are listed on the Nasdaq Helsinki Stock Exchange under 'HEALTH FH'.
This strategic move aims to provide U.S. investors easier access to Nightingale Health's shares, aligning with the company's global expansion strategy, particularly in the U.S. healthcare market. The partnership leverages Citi's global network through its Issuer Services business, which operates depositary receipt programs across 65 markets.
Citi è stata nominata banca depositaria per il programma di American Depositary Receipt (ADR) di livello 1 sponsorizzato da Nightingale Health OYJ. Gli ADR dell'azienda sono negoziati sulla piattaforma OTCQX con il simbolo 'NHLTY', con ogni ADR che rappresenta un'azione ordinaria. Le azioni ordinarie sottostanti sono quotate sulla Borsa di Helsinki Nasdaq con il simbolo 'HEALTH FH'.
Questa mossa strategica mira a fornire agli investitori statunitensi un accesso più semplice alle azioni di Nightingale Health, in linea con la strategia di espansione globale dell'azienda, in particolare nel mercato sanitario statunitense. La partnership sfrutta la rete globale di Citi attraverso il suo business di Servizi per Emittenti, che gestisce programmi di ricevute di deposito in 65 mercati.
Citi ha sido designada como el banco depositario para el programa de American Depositary Receipt (ADR) de nivel 1 patrocinado por Nightingale Health OYJ. Los ADR de la empresa se negocian en la plataforma OTCQX bajo el símbolo 'NHLTY', con cada ADR representando una acción ordinaria. Las acciones ordinarias subyacentes están listadas en la Bolsa de Valores de Helsinki Nasdaq bajo 'HEALTH FH'.
Este movimiento estratégico tiene como objetivo proporcionar a los inversores estadounidenses un acceso más fácil a las acciones de Nightingale Health, alineándose con la estrategia de expansión global de la empresa, especialmente en el mercado de salud de EE. UU. La asociación aprovecha la red global de Citi a través de su negocio de Servicios al Emisor, que opera programas de recibos de depósito en 65 mercados.
씨티(Citi)는 나이팅게일 헬스 OYJ(Nightingale Health OYJ)가 후원하는 1급 미국 예탁 증서(ADR) 프로그램의 예탁은행으로 임명되었습니다. 회사의 ADR은 OTCQX 플랫폼에서 'NHLTY'라는 기호로 거래되며, 각 ADR은 하나의 보통주를 나타냅니다. 기본 보통주는 헬싱키 나스닥 증권 거래소에 'HEALTH FH'라는 기호로 상장되어 있습니다.
이 전략적 조치는 미국 투자자들이 나이팅게일 헬스의 주식에 더 쉽게 접근할 수 있도록 하여, 특히 미국 헬스케어 시장에서의 회사의 글로벌 확장 전략과 일치합니다. 이 파트너십은 씨티(Citi)의 발행인 서비스 비즈니스를 통해 65개 시장에서 예탁 증서 프로그램을 운영하는 글로벌 네트워크를 활용합니다.
Citi a été désignée comme banque dépositaire pour le programme de American Depositary Receipt (ADR) de niveau 1 sponsorisé par Nightingale Health OYJ. Les ADR de l'entreprise se négocient sur la plateforme OTCQX sous le symbole 'NHLTY', chaque ADR représentant une action ordinaire. Les actions ordinaires sous-jacentes sont cotées sur la Bourse de Helsinki Nasdaq sous 'HEALTH FH'.
Ce mouvement stratégique vise à offrir aux investisseurs américains un accès plus facile aux actions de Nightingale Health, s'alignant sur la stratégie d'expansion mondiale de l'entreprise, en particulier sur le marché de la santé aux États-Unis. Le partenariat tire parti du réseau mondial de Citi grâce à son activité de Services aux Émetteurs, qui gère des programmes de reçus de dépôt dans 65 marchés.
Citi wurde als Depotbank für das von Nightingale Health OYJ gesponserte Level-1-Programm für American Depositary Receipts (ADR) ernannt. Die ADRs des Unternehmens werden auf der Plattform OTCQX unter dem Symbol 'NHLTY' gehandelt, wobei jede ADR eine Stammaktie repräsentiert. Die zugrunde liegenden Stammaktien sind an der Nasdaq Helsinki Stock Exchange unter 'HEALTH FH' gelistet.
Dieser strategische Schritt zielt darauf ab, US-Investoren einen einfacheren Zugang zu den Aktien von Nightingale Health zu ermöglichen, was mit der globalen Expansionsstrategie des Unternehmens, insbesondere im US-Gesundheitsmarkt, übereinstimmt. Die Partnerschaft nutzt Citis globales Netzwerk über das Geschäftsfeld Emittentenservices, das Depotreceiptsprogramme in 65 Märkten betreibt.
- Expanded access to U.S. investors through ADR program
- Strategic entry into world's largest healthcare market
- Partnership with major global financial institution (Citi)
- Enhanced trading accessibility for international investors
- None.
Nightingale Health’s ADRs are traded on the OTCQX platform under the symbol “NHLTY”. Each ADR represents one ordinary share of the company. Nightingale Health’s underlying ordinary shares are listed and traded on the Nasdaq Helsinki Stock Exchange under the symbol “HEALTH FH”.
“We are excited to work with Citi on our ADR program which enables U.S. investors to easily trade our shares,” said Teemu Suna, Nightingale Health’s CEO and Founder. “Our ambitions are highly global, and the
Dirk Jones, Head of Issuer Services at Citi said: “By leveraging Citi’s global network, we have the ability to support issuers to expand and diversify their shareholder base by accessing global capital markets. Through our Issuer Services business, Citi offers a high-quality ADR service which will facilitate the success of Nightingale Health’s Level 1 ADR program.”
Citi Issuer Services is a leading provider of depositary receipt services. With depositary receipt programs in over 65 markets, spanning equity and fixed-income products, Issuer Services leverages Citi’s global network to provide cross-border capital market access to issuers, intermediaries, and investors.
For more information on Citi’s depositary receipt services, visit www.citi.com/dr.
About Citi
Citi is a preeminent banking partner for institutions with cross-border needs, a global leader in wealth management and a valued personal bank in its home market of
Additional information may be found at www.citigroup.com | X: @Citi | LinkedIn: www.linkedin.com/company/citi | YouTube: www.youtube.com/citi | Facebook: www.facebook.com/citi
About Nightingale Health
Nightingale Health has developed the world’s most advanced health check. Our solution provides risk detection for multiple chronic diseases from a single blood sample. Nightingale Health Check can be scaled to entire populations and can replace many of the current routine disease risk assessments and health screening programs for chronic diseases. Detecting disease risks comprehensively and efficiently allows effective targeting and tracking of health interventions, and better prevention of chronic diseases. Nightingale Health’s mission is to build sustainable healthcare and reduce health inequalities. With every sample Nightingale Health helps to create a healthier world.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250325190873/en/
Citi Media Contact:
Harsha Jethnani
harsha.jethnani@citi.com
+65 93830872
Nightingale Health Investor Contact:
Teemu Suna, CEO
ir@nightingalehealth.com
Source: Citi
FAQ
What is the conversion ratio for Nightingale Health's ADR (NHLTY) to ordinary shares?
Where are Nightingale Health's ADRs traded and under what symbol?
What is the purpose of Nightingale Health's ADR program with Citi?
What is Citi's role in Nightingale Health's ADR program?
